Use of beta-blocker and mortality in patients with coronary artery disease with or without COPD: a retrospective data analysis

被引:0
|
作者
Rezaei, S. Sheikh [1 ]
Rinner, C. [1 ]
Ratajczak, P. [1 ]
Grossmann, W. [1 ]
Gall, W. [1 ]
Wolzt, M. [1 ]
机构
[1] Med Univ Wien, Univ Klin Klin Pharmakol, Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
9-3
引用
收藏
页码:S59 / S59
页数:1
相关论文
共 50 条
  • [41] Effect of beta-blocker dose on mortality after acute coronary syndrome
    Raposeiras-Roubin, Sergio
    Abu-Assi, Emad
    Caneiro-Queija, Berenice
    Cobas-Paz, Rafael
    Rioboo-Leston, Lucia
    Garcia Rodriguez, Cristina
    Giraldez Lemos, Cruz
    Blanco Vidal, Maria
    Ogando Guillan, Beatriz
    Perez Martinez, Isabel
    Paredes-Galan, Emilio
    Jimenez-Diaz, Victor
    Antonio Baz-Alonso, Jose
    Calvo-Iglesias, Francisco
    Iniguez-Romo, Andres
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2018, 37 (03) : 239 - 245
  • [42] The association of beta-blocker use with mortality in elderly patients with congestive heart failure and advanced chronic kidney disease
    Molnar, Amber O.
    Petrcich, William
    Weir, Matthew A.
    Garg, Amit X.
    Walsh, Michael
    Sood, Manish M.
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2020, 35 (05) : 782 - 789
  • [43] CHRONIC BETA-BLOCKER USE IS NOT ASSOCIATED WITH REDUCED IN-HOSPITAL MORTALITY IN CRITICALLY ILL PATIENTS WITH LIVER DISEASE
    Lindenmeyer, Christina C.
    Kim, Ahyoung J.
    Sanghi, Vedha
    Lopez, Rocio
    Niyazi, Fadi
    Mehta, Neal
    Kapoor, Aanchal
    Romero-Marrero, Carlos
    GASTROENTEROLOGY, 2017, 152 (05) : S1143 - S1143
  • [44] Diltiazem as an Alternative to Beta-blocker in Coronary Artery Computed Tomography Angiography
    Rochitte, Carlos Eduardo
    Antunes Azevedo, Guilherme Santana
    Shiozaki, Afonso Akio
    Azevedo, Clerio Francisco
    Kalil Filho, Roberto
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2012, 99 (02) : 706 - 712
  • [45] Beta-blocker use and mortality among patients with systolic heart failure and pacemaker rhythm
    Perry, Andrew S.
    Maggioni, Aldo P.
    Tavazzi, Luigi
    Levy, Wayne C.
    ESC HEART FAILURE, 2023, 10 (03): : 1972 - 1979
  • [46] LOW RATES OF BETA-BLOCKER USE FOR INCIDENT EVENTS OF ISCHAEMIC HEART DISEASE IN HOSPITALISED PATIENTS WITH ACUTE EXACERBATIONS OF COPD
    Lim, K.
    Loughrey, S.
    Lavender, M.
    Musk, M.
    Wrobel, J.
    RESPIROLOGY, 2015, 20 : 104 - 104
  • [47] Effect of beta-blocker use on mortality in patients with atrial fibrillation. A cohort study
    Fauchier, L.
    Clementy, N.
    Bisson, A.
    Angoulvant, D.
    Angoulvant, T. Bejan
    Bernard, A.
    Ivanes, F.
    Babuty, D.
    Lip, G. Y. H.
    EUROPEAN HEART JOURNAL, 2016, 37 : 290 - 290
  • [48] Effect of beta-blocker therapy in patients with coronary artery disease in New York Heart Association classes II and III
    Haim, M
    Shotan, A
    Boyko, V
    Reicher-Reiss, H
    Benderly, M
    Goldbourt, U
    Behar, S
    AMERICAN JOURNAL OF CARDIOLOGY, 1998, 81 (12): : 1455 - 1460
  • [49] COMBINATION CALCIUM BLOCKER AND BETA-BLOCKER THERAPY IS SUPERIOR TO MONOTHERAPY FOR PREVENTING EXERCISE INDUCED ISCHEMIA IN PATIENTS WITH SEVERE CORONARY-ARTERY DISEASE
    MILLER, WE
    VITTITOE, JA
    OROURKE, RA
    CRAWFORD, MH
    CLINICAL RESEARCH, 1987, 35 (03): : A306 - A306
  • [50] Lower Tolerated Beta-Blocker Dosage in Indonesian Population: a Pilot Study in Heart Failure and Coronary Artery Disease Patients
    Nuari, Hans
    Damay, Vito A.
    Tanaka, Michael
    Aziz, Melisa
    Sukmawati, Indah
    EUROPEAN HEART JOURNAL SUPPLEMENTS, 2019, 21 (0F) : F67 - F68